Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies
Tumor Biology · 30.08.2021 · 43 (1) · 225-247
DOI: 10.3233/tub-211506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 14.09.2021. Verfasst von Mostafa A Askar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Biology, National Center for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: The limitations of surgery, radiotherapy, and chemotherapy in cancer treatment and the increase in the application of nanomaterials in the field of biomedicine have promoted the use of nanomaterials in combination with radiotherapy for cancer treatment. OBJECTIVE: To improve the efficiency of cancer treatment, curcumin-naringenin loaded dextran-coated magnetic nanoparticles (CUR-NAR-D-MNPs) were used as chemotherapy and in combination with radiotherapy to verify their effectiveness in treating tumors. METHODS: CUR-NAR-D-MNPs were prepared and studied by several characterization methods. Median inhibitory concentration (IC50) and cellular toxicity were evaluated by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay. The cell death and radiosensitization were studied by acridine orange/ethidium bromide dual staining of MCF-7 human breast cancer cells. RESULTS: CUR-NAR-D-MNPs induce apoptosis and inhibited cell proliferation through reactive oxygen species (ROS) generation. CUR-NAR-D-MNPs used alone had a certain therapeutic effect on tumors. CUR-NAR-D-MNPs plus radiotherapy significantly reduced the tumor volume and led to cell cycle arrest and induction of apoptosis through modulation of P53 high , P21 high , TNF-α low , CD44 low , and ROS high signaling CONCLUSIONS: CUR-NAR-D-MNPs are effective in the treatment of tumors when combined with radiotherapy, and show radiosensitization effects against cancer proliferation in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Biology, National Center for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt.
- Department of Health and Radiation Research, National Center for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt.
- Department of Biochemistry, Faculty of Veterinary Medicine, Moshtohor, Benha University, Benha, Egypt.
- Department of Petrochemicals, Petroleum Research Institute, Cairo, Egypt.
Zitieren
APA
Askar, M. A., El Shawi, O. E., Abou Zaid, O. A. R., Mansour, N. A., & Hanafy, A. M. (2021). Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies. Tumor Biology, 43(1), 225-247. https://doi.org/10.3233/tub-211506
Vancouver
Askar MA, El Shawi OE, Abou Zaid OAR, Mansour NA, Hanafy AM. Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies. Tumor Biology. 2021;43(1):225-247. doi:10.3233/tub-211506
BibTeX
@article{Askar2021,
author = {Askar, Mostafa A and El Shawi, Omama E and Abou Zaid, Omayma A R and Mansour, Nahla A and Hanafy, Amal M},
title = {Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies},
journal = {Tumor Biology},
year = {2021},
volume = {43},
number = {1},
pages = {225--247},
doi = {10.3233/tub-211506}
}
EUVIMED